5443092025-01-012025-03-315443092025-03-315443092024-03-315443092024-04-012025-03-315443092025-01-012025-03-31in-capmkt:OtherExpenses1Member5443092024-04-012025-03-31in-capmkt:OtherExpenses1Member5443092025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15443092024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss25443092025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15443092025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25443092024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15443092024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss25443092025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544309IKSNOTLISTEDINE115Q01022INVENTURUS KNOWLEDGE SOLUTIONS LIMITEDMain BoardEquity2024-04-012025-03-312025-05-152025-04-23INRMillionsQuarterlyFourth quarterSingle segmentCARE ENABLEMENT PLATFORM PROVIDING TECHNOLOGY ENABLED SOLUTIONS TO HEALTHCARE PROVIDERS2025-05-1519:20:002025-05-1520:35:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31UnauditedConsolidated72395600003261000072721700000003865500000210190000283330000111230000054713200001800850000018008500001639700001588600003228300000147802000000001478020000629750000210777000017023000008.888.7008.888.7Notes to the Statement of Audited Consolidated and Standalone Financial Results for the year ended March 31 2025 <BR> <BR> The above standalone financial results of Inventurus Knowledge Solutions Limited and consolidated financial results of the Company and its subsidiaries collectively the Group for the quarter and year ended March 31 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in its meeting held on May 15 2025 The above results for the year ended March 31 2025 have been audited by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBl Listing Obligations and Disclosure Requirements Regulations 2015 as amended The figures for the quarter ended March 31 2024 as reported in the statement have been approved by the Companys Board of Directors but have not been subjected to limited review since the requirement of submission of quarterly financial results is applicable on listing of equity shares of the Company from the quarter ended December 31 2024 <BR> <BR> The statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder. <BR> <BR> The figures of the quarter ended March 31 2025 and March 31 2024 are balancing figure between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the respective financial years <BR> <BR> The Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers This in the context of Indian Accounting Standard Operating Segments constitutes a single operating segment <BR> <BR> The Company has allotted 464800 shares previous period 123398 shares for the quarter and 648002 shares previous year 852798 shares for the year ended March 31 2025 on exercise of Employee Stock options Accordingly the Company has transferred Rs 106.18 million to the Securities Premium during the year ended March 31 2025 <BR> <BR> The Board at their meeting held on April 22 2022 approved the 2022 Plan for issue of shares or options to key employees of the Company and its subsidiaries. During the quarter and year ended March 31 2025 the Company has granted Nil and 3699840 stock options respectively to eligible employees as approved in the Nomination and Remuneration Committee meeting The related share based compensation expense for the quarter and year ended March 31 2025 is Rs 110.05 million and Rs 277.31 million respectively <BR> <BR> Earnings per share for the interim periods are not annualised <BR> <BR> The consolidated financial results of the Group include the results of its subsidiary companies viz Inventurus Knowledge Solutions Inc, IKS Cares Foundation and its step down subsidiary companies viz: Aquity Holdings Inc Aquity Solutions LLC Aquity Solutions India Private Limited Aquity Solutions Australia Pty Limited and Aquity Canada ULC <BR> <BR> The figures appearing in the year ended March 31 2024 of the consolidated financial results includes figures of Aquity Holdings Inc acquired on October 27 2023 and hence are not comparable with the March 31 2025 presented above2024-04-012025-03-31AuditedConsolidated26639940000389980000270299200000074700001494606000089765000011266300003989290000209671000006062820000060628200001247550000-4532000012022300000486059000000004860590000681610000554220000017023000001772670000029.228.620029.228.62Other expenses1112300000Other expenses3989290000412420000534200001197263000055154600007709000011373700002165400000111437000024682800001859930000320440000226796700000053205900001804220000118820000026369000075073200003313900007838710000305183800001702300001772670000017896930000017896930000509272000077459000058673100002008500001324910000016610000740968000024576700001419000074537000075956000030385000035210800001010540000514380000165770000052117700001262145000030518380000Not Applicable refere note 4 of the Statement of audited financial results for the quarter and financial year ended March 31 20258976500007570000-20348400000-84450000-889800000003269100000-5440000-47764000011266300000-1663600000-118730000004560000012945000027731000017470000000-2061600000-17225200004340300000000116142000003178880000064449000000000051400002469100001514710000001768700000000000000000026151000001731400000244449000000667830000022955000000003281310000317660000073416000000-38948500001728520000-321400001696380000-2348300001461550000Remeasurement of post employment benefit obligations-2440000Changes in the fair value of equity investments at FVOCI689350000686910000Remeasurement of post employment benefit obligations-18150000Changes in the fair value of equity investments at FVOCI691400000673250000178720000176690000Gains/ (losses) on cash flow hedges (net)179930000Exchange differences on translation of financial statements of foreign operations-30600000149330000Gains/ (losses) on cash flow hedges (net)-39420000Exchange differences on translation of financial statements of foreign operations21759000017817000027770000-6880000629750000681610000AuditedtruePrice Waterhouse Chartered Accountants LLPtrue2026-11-30